Skip to content

Impact of a Letter Encouraging Pneumococcal Vaccination on the 1-year Vaccination Rate in Heart Failure Patients With a Primary Care Physician

Impact of a Letter Encouraging Pneumococcal Vaccination on the 1-year Vaccination Rate in Heart Failure Patients With a Primary Care Physician

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06360315
Enrollment
12000
Registered
2024-04-11
Start date
2023-01-02
Completion date
2024-06-30
Last updated
2024-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Keywords

Heart failure, Hospitalization, Pneumococcal vaccination

Brief summary

Heart failure affects more than 1.5 million people in France, resulting in over 70,000 deaths and more than 165,000 hospitalizations each year. Viral and bacterial infections are frequently associated with episodes of acute heart failure in patients with chronic heart failure (CHF). Lower respiratory tract infections, such as influenza and pneumococcus, are common causes of hospitalization for decompensated heart failure, leading to increased morbidity and mortality. Studies have shown that pneumococcal vaccination can reduce the risks of heart attack or stroke in patients with heart failure. However, despite vaccination recommendations, coverage rates remain low, especially for pneumococcus. In this study, we will evaluate the impact of an incentive letter for pneumococcal vaccination on one-year hospitalization rate in patients with heart failure.

Interventions

OTHERIncentive letter for pneumococcal vaccination to the patient and to the GP

Incentive letter for pneumococcal vaccination to the patient and to the GP

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients over 45 * Residing in the Occitanie region, France * With heart failure registered as ALD * Who have declared an attending physician * Who have not received a pneumococcal vaccination for more than 24 months (due to the length of time available in the database)

Exclusion criteria

-None

Design outcomes

Primary

MeasureTime frame
1-year Pneumococcus vaccination rateat 1-year

Secondary

MeasureTime frame
1-year all-cause hospital admission rateat 1-year
1-year specific hospital admission rateat 1-year
1-year all-cause mortality rateat 1-year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026